유지영 (University of Texas Health Science Center at Houston)님 | 한빛사연구자 > 한빛사

University of Texas Health Science Center at Houston

최종업데이트 2024.06.21.

Overcoming IGF1R-mediated resistance to oncolytic HSV1 and radiotherapy via triple combination therapy
- Cell Death Dis., Jul 17 2026, | https://doi.org/10.1038/s41419-026-09090-5
- 2026-07
- 한빛사논문
Simultaneous Targeting of Tumor Cells and Tumor-Associated Macrophages To Reprogram Glioblastoma Using Trypsinized Extracellular Vesicles Carrying Tumor Suppressive MicroRNA
- Nano Lett., May 13 2025, | https://doi.org/10.1021/acs.nanolett.5c01897
- 2025-05
- 생명과학
- 한빛사논문
Targeting IGF2-IGF1R Signaling to Reprogram the Tumor Microenvironment for Enhanced Viro-Immunotherapy
- Neuro-Oncology, Jun 10 2024, noae105 | https://doi.org/10.1093/neuonc/noae105
- 2024-06
- 한빛사논문
Complex role of NK cells in regulation of oncolytic virus–bortezomib therapy
- Proc. Natl. Acad. Sci. USA, April 23, 2018, 201715295 | https://doi.org/10.1073/pnas.1715295115
- 2018-04
- 한빛사논문

연구자 ID

저자논문